giovannelli-associati-logogiovannelli-associati-logo-stickygalaw-giovannelli-e-associati-logo-mobile-centro-130×35giovannelli-associati-logo
  • HOME
  • OUR FIRM
    • About us
    • International strategy
  • TEAM
    • Partners
    • Of Counsel
    • Associates
  • PRACTICE AREAS
    • Mergers and Acquisitions – Private Equity
    • Finance & Restructuring
    • Capital Markets
    • Corporate and Commercial matters
    • Intellectual Property
    • Labour Law
    • Litigation and Arbitration
    • Privacy
    • Tax
  • MEDIA
  • WORK WITH US
  • CONTACTS
English
  • Italian
✕
Giovannelli e Associati tops M&A Legal Advisors League Tables according to Mergermarket
09/07/2019
Giovannelli e Associati advised Nutrilinea on its investment in Claire
25/07/2019
Mostra tutto

Giovannelli e Associati advised Nutrilinea on its investment in Apharm

Pubblicato da Giovannelli e Associati il 24/07/2019
giovannelli-associati-news-delucchi

Giovannelli e Associati advised Nutrilinea on its investment in Apharm.

Nutrilinea S.r.l. is a leading company specializing in designing and manufacturing of food supplements and medical devices.

Apharm is a pharmaceutical company whose core business is the research and development of new products and registration of innovative patents that are licensed all over the world. Apharm operates in the most important medical fields.

The team of Giovanelli e Associati was led by corporate partner Matteo Delucchi and by finance partner Michele Mocarelli. They were supported by associates Beatrice Riva, Matteo Bruni and Maria Costa.

Read More:

Nutrilinea – Apharm – Legalcommunity
Nutrilinea-Apharm – Press release
Nutrilinea-Apharm – TopLegal – 27.06.2019
Nutrilinea-Apharm Comunicato Stampa 06.06.2019
Condividi

Media correlati

10/08/2022

Giovannelli e Associati advised Neopharmed Gentili on the acquisition of the entire share capital of Valeas


Leggi tutto
29/07/2022

Giovannelli e Associati with Neva SGR on the investment round of Casavo


Leggi tutto
20/07/2022

Giovannelli e Associati with Blacksheep Madtech Fund on the investment round of iGenius


Leggi tutto

Cerca news e media

✕

Latest News&Media

  • Giovannelli e Associati advised Neopharmed Gentili on the acquisition of the entire share capital of Valeas
    10/08/2022
  • Giovannelli e Associati with Neva SGR on the investment round of Casavo
    29/07/2022
  • Giovannelli e Associati with Blacksheep Madtech Fund on the investment round of iGenius
    20/07/2022

Categories

  • Articles
  • Giovannelli e Associati @en
  • HOT TOPICS: LABOUR
  • HOT TOPICS: TAX
  • News
  • Press Release

Pratice Areas

  • Mergers and Acquisitions – Private Equity
  • Finance & Restructuring
  • Capital Markets
  • Corporate and Commercial matters
  • Intellectual Property
  • Labour Law
  • Litigation and Arbitration
  • Privacy
  • Tax
© Copyright 2021 Giovannelli e Associati | Via dei Bossi, 4 20121 Milano, Italia | P.IVA 08347040969 | Note Legali | Privacy Policy | Credits